New pancreatic cancer drug offers hope but raises access questions with a hefty price tag
A newly approved pancreatic cancer drug is offering new hope for some patients, but its nearly half-million-dollar price…
Epinephrine injections recalled over sterility concerns
FDA announces nationwide recall of epinephrine injections over sterility and particulate concerns A nationwide voluntary recall of three…
‘Blockbuster’ reatrutide is coming. Will it help Louisiana? | Louisiana Health
A new obesity medication is coming, one that may prove a “blockbuster” in states like Louisiana that struggle with…
How GLP-1-Taking Dietitians Are Changing the Medication’s Stigma
10 min read Something strange started happening to Gianna Beasley four years ago. Despite doing everything right with…
Bridge to Fit: Before you start GLP-1 medications, read this
Now, I’m not a doctor, so I’m not recommending or not recommending weight loss drugs, period. That’s a…
Epinephrine injections recalled over sterility concerns
FDA announces nationwide recall of epinephrine injections over sterility and particulate concerns A nationwide voluntary recall of three…
FDA tracking hundreds of reports tied to compounded weight-loss drugs, unapproved peptides
(WBAY) – The FDA is tracking hundreds of reported problems involving compounded weight-loss medications, as unapproved peptide products…
Hack of the day: How to find your nearest Jan Aushadhi store
Affordable healthcare is a pressing concern for millions of patients across India. Government-supported Jan Aushadhi stores provide generic…
NZ’s new medicines fast-track promises quicker approvals. But what about access?
A surge in severe respiratory illness has been placing New Zealand’s hospitals under intense pressure over recent weeks.…
The Third Global Summit on Traditional Medicine set for November 2027
© WHO Dr Rajesh Kotecha, Secretary, Ministry of Ayush, Government of India (centre); Dr Pongsadhorn Pokpermdee, Director General, Department…
GLP-1 Scripts Rising Faster Among Adults With Serious Mental Illness
People with serious mental illness (SMI) face high cardiovascular risk, making GLP-1 drugs a potential tool to reduce…
Mounjaro: FDA Approves GLP-1 for Cardiovascular Risk Reduction
Share on PinterestThe FDA has approved Mounjaro for cardiovascular risk reduction in people with type 2 diabetes. Milko…